| Fund ID | 805-4775335053 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 2% |
| Owned by funds of funds | 48% |
| Owned by non-U.S. persons | 17% |
| Fund | Type | Gross assets |
|---|---|---|
| Tpg Partners VIII, L.P. | Private Equity | $15.21B |
| Tpg Partners IX, L.P. | Private Equity | $12.32B |
| Tpg Rise Climate, L.P. | Private Equity | $9.2B |
Tpg Life Sciences Innovations, L.P. reports $434.1 million in gross assets, among the top 17% of private funds by size.
The stated minimum investment is $10 million.
Tpg Life Sciences Innovations, L.P. is managed by Tpg Capital Advisors, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.